Latest Breaking News On - Paulf hickey - Page 1 : vimarsana.com

ReShape Lifesciences Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update

ReShape Lifesciences Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Fort worthUnited statesPaulf hickeyAdam smithChristine renMichael millerDevelopment expenses researchExchange commissionMaxim groupGrossman school of medicineReduction in forceLangone health weight management programTrademark officeLifesciences inc nasdaqDivision of bariatric surgeryConference call

Reshape Lifesciences® Reports Year Ended December 31, 2023 Financial Results And Provides Corporate Update

Reshape Lifesciences® Reports Year Ended December 31, 2023 Financial Results And Provides Corporate Update
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesFort worthChristine renPaulf hickeyAdam smithMichael millerLangone weight management programTrademark officeDrug administrationDivision of bariatric surgeryRx communications groupLangone health weight management programLifesciences incMaxim groupGrossman school of medicineExchange commission

ReShape Lifesciences® Receives Notice of Allowance for

Patent Significantly Strengthens Intellectual Property Portfolio.

United statesMichael millerPaulf hickeyExchange commissionTrademark officeRx communications groupShape lifesciencesPatent term extensionChief executive officerReshape lifesciencesDiabetes bloc stim neuromodulationPrivate securities litigation reform actAnnual reportQuarterly reportsShape lifesciences investor contactChief executive

ReShape Lifesciences® Receives Notice of Allowance for Additional U S Patent Related to an

IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that the company has received a Notice

United statesPaulf hickeyMichael millerRx communications groupTrademark officeExchange commissionShape lifesciencesPatent term extensionChief executive officerReshape lifesciencesDiabetes bloc stim neuromodulationPrivate securities litigation reform actAnnual reportQuarterly reportsShape lifesciences investor contactChief executive

ReShape Lifesciences Announces First Surgeries Utilizing Next-Generation Lap-Band 2 0 FLEX

22.02.2024 - FLEX Technology Designed to Enhance the Patient Experience Surgeon Training Underway for the Initial Launch of the Lap-Band 2.0 FLEX IRVINE, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) - ReShape Lifesciences (Nasdaq: RSLS), the premier physician-led .

Paulf hickeyExchange commissionChief executive officerShape lifesciencesLap band systemDiabetes bloc stim neuromodulationPrivate securities litigation reform actAnnual reportQuarterly reportsShape lifesciences investor contactChief executive